Graf Akcie BMY (Bristol-Myers Squibb Co.). Diskuze k akciím BMY. Aktuální informace BMY.

Základní informace o společnosti Bristol-Myers Squibb Co. (Akcie BMY)

Skvělé pro velmi rychlou analýzu společnosti. Investor může porovnat různé ukazatele s konkurenčními firmami.

Tržní kapitalizace 131.44B
Hodnota podniku (EV) 166.25B
Tržby 44.384B
EBITDA 14.153B
Zisk -5.08
Růst v tržbách Q/Q 15.54 %
Růst v tržbách Y/Y 27.31 %
P/E (Cena vůči ziskům) N/A
Forward P/E 20.73
EV/Sales 3.75
EV/EBITDA 11.75
EV/EBIT N/A
PEG 14.08
Price/Sales 2.96
P/FCF 11.00
Price/Book 3.48
Účetní hodnota na akcii 16.48
Hotovost na akcii 6.90
FCF vůči ceně 9.09 %
Počet zaměstnanců 30,250
Tržba na zaměstnance 1467000
Profit margin -21.20 %
Operating margin -9.26 %
Gross margin 72.31 %
EBIT margin -9.31 %
EBITDA margin 31.89 %
EPS - Zisk na akcii N/A
EPS - Kvartální růst 18.40 %
EPS - Očekávaný růst příští rok 18.40 %
Return on assets -4.35 %
Return on equity -12.51 %
ROIC -5.55 %
ROCE -4.50 %
Dluhy/Equity 2.13
Čistý dluh/EBITDA 8.77
Current ratio 1.54
Quick Ratio 1.42
Volatilita 1.90
Beta 0.61
RSI 21.64
Cílová cena analytiků 74
Známka akcie (dle analytiků) 1.70
Insider ownership 0.07 %
Institutional ownership 75.45 %
Počet akcií 2.222B
Procento shortovaných akcií 0.95 %
Short ratio 2.57 %
Dividenda 1.96
Procentuální dividenda 3.32 %
Dividenda/Zisk 275.00 %
Obchodovaná od 1978
Země United States

Finanční výsledky akcie BMY

Finanční výsledky společnosti, napoví investorovi, zda se jedná o kvalitní společnost.

# 2020 2019 2018 2017 2016 2015
Revenue$42,518$26,145$22,561$20,776$19,427$16,560
Cost Of Goods Sold$11,773$8,078$6,467$6,014$4,969$3,909
Gross Profit$30,745$18,067$16,094$14,762$14,458$12,651
Research And Development Expenses$11,143$6,148$6,332$6,468$5,012$5,920
SG&A Expenses$7,661$4,871$4,551$4,751$4,979$4,841
Other Operating Income Or Expenses$-9,124$-938$854$1,685$1,448$187
Operating Expenses$49,389$21,170$16,593$15,645$13,512$14,483
Operating Income$-6,871$4,975$5,968$5,131$5,915$2,077
Total Non-Operating Income/Expense------
Pre-Tax Income$-6,871$4,975$5,968$5,131$5,915$2,077
Income Taxes$2,124$1,515$1,021$4,156$1,408$446
Income After Taxes$-8,995$3,460$4,947$975$4,507$1,631
Other Income------
Income From Continuous Operations$-8,995$3,460$4,947$975$4,507$1,631
Income From Discontinued Operations------
Net Income$-9,015$3,439$4,920$1,007$4,457$1,565
EBITDA$3,509$6,721$6,605$5,920$6,297$2,453
EBIT$-6,871$4,975$5,968$5,131$5,915$2,077
Basic Shares Outstanding2,2581,7051,6331,6451,6711,667
Shares Outstanding2,2581,7121,6371,6521,6801,679
Basic EPS$-3.99$2.02$3.01$0.61$2.67$0.94
EPS - Earnings Per Share$-3.99$2.01$3.01$0.61$2.65$0.93
# 2020 2019 2018 2017 2016 2015
Current Ratio1.58241.60371.66291.55331.55011.2991
Long-term Debt / Capital0.56060.45630.28550.37060.25910.3123
Debt/Equity Ratio1.33770.9040.52020.67210.41040.4637
Gross Margin72.310669.103171.335571.053174.422276.3949
Operating Margin-16.160219.028526.452724.696830.447312.5423
EBIT Margin-16.160219.028526.452724.696830.447312.5423
EBITDA Margin8.25325.706629.276228.494432.413714.8128
Pre-Tax Profit Margin-16.160219.028526.452724.696830.447312.5423
Net Profit Margin-21.202813.153621.80754.846922.94239.4505
Asset Turnover0.35890.20120.64490.61920.57630.5216
Inventory Turnover Ratio5.67651.88175.41175.15784.0043.2015
Receiveable Turnover5.00153.40213.92573.29783.50483.8521
Days Sales In Receivables72.9777107.287292.977110.6806104.143594.7545
ROE - Return On Equity-23.74486.692735.01818.229927.570811.3075
Return On Tangible Equity25.0501-9.954376.131125.834755.731426.6329
ROA - Return On Assets-7.59192.662714.13992.90613.37115.1373
ROI - Return On Investment-10.43293.638825.0195.180120.42797.7763
Book Value Per Share17.056323.20388.69897.29059.82398.6839
Operating Cash Flow Per Share1.42760.47921.12331.37290.5665-0.6313
Free Cash Flow Per Share1.58250.57171.1811.45750.3317-0.8048

Porovnání s konkurencí: Akcie BMY

Společnost P/E PEG Růst v tržbách (roční) Růst v EPS Return on equity P/B Profit margin
BMY N/A 14.08 27.31 % 18.40 % -12.51 % 3.48 -21.20 %
Akcie ABBV 30.30 1.28 48.31 % 14.49 % 48.79 % 14.98 10.08 %
Akcie ABT 33.16 2.96 27.95 % -5.10 % 19.26 % 6.35 12.99 %
Akcie AZN 42.09 1.02 14.90 % 40.43 % 26.02 % 10.28 11.81 %
Akcie JNJ 23.88 1.67 10.79 % 7.27 % 27.01 % 6.71 17.82 %
Akcie LLY 34.91 1.63 16.46 % 27.92 % 101.98 % 39.02 25.24 %
Akcie MRK 37.25 1.38 2.87 % 13.14 % 19.42 % 8.07 14.72 %
Akcie MYL 32.42 0.68 1.11 % -2.86 % 2.25 % 0.72 N/A %
Akcie PFE 18.11 1.97 4.96 % 50.00 % 19.81 % 3.81 22.95 %

Nedávné obchody insiderů: Akcie BMY

Jméno Obchod Cena Objem
Adam Dubow
SVP, ChiefCompliance, and EthicsOff.
Prodej
24 Nov 2020
$63.39 $57,051
Autenried Paul Von
EVP and Chief Information Officer
Prodej
25 Nov 2020
$63.50 $191
Joseph Eid
SVP and Head Glob. Medical Affairs
Option
1 Dec 2020
$62.41 $176,308
Christopher S. Boerner
EVP and Chief Commercial Officer
Option
2 Dec 2020
$62.18 $163,969
David V Elkins
EVP and Chief Financial Officer
Option
2 Dec 2020
$62.18 $546,687
Nadim Ahmed
EVP, President, and Hematology
Option
2 Dec 2020
$62.18 $410,015
Rupert Vessey
EVP, Research, and Early Dev.
Option
2 Dec 2020
$62.18 $546,687
Nadim Ahmed
EVP, President, and Hematology
Option
31 Dec 2020
$62.03 $927,100
David V Elkins
EVP and Chief Financial Officer
Option
31 Dec 2020
$62.03 $1,279,307
Rupert Vessey
EVP, Research, and Early Dev.
Option
31 Dec 2020
$62.03 $1,604,468
Rupert Vessey
EVP, Research, and Early Dev.
Option
4 Feb 2021
$61.56 $221,124

Diskuze k akciím BMY